Emergent BioSolutions Inc: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Emergent BioSolutions Inc Unternehmen

Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial Products segment include NARCAN (naloxone HCl). MCM Products segment consists of its Anthrax - MCM, Smallpox - MCM and Other Products. Services segment consisting of its Bioservices offerings. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Its portfolio of Bioservices consists of three but interrelated service pillars, such as development services (process and analytical development) and drug substance manufacturing.

Emergent BioSolutions Inc Informationen



BörsenkürzelEBS

Name des UnternehmensEmergent BioSolutions Inc

IPO-datumNov 15, 2006

CEOMr. Joseph C. (Joe) Papa

Anzahl der mitarbeiter900

WertpapierartOrdinary Share

GeschäftsjahresendeNov 15

Addresse300 Professional Dr

StadtGAITHERSBURG

BörseNYSE Consolidated

LandUnited States of America

Postleitzahl20879

Telefon12406313200

Websitehttps://emergentbiosolutions.com/

BörsenkürzelEBS

IPO-datumNov 15, 2006

CEOMr. Joseph C. (Joe) Papa

Führungskräfte von Emergent BioSolutions Inc



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Joseph C. (Joe) Papa

President, Chief Executive Officer, Director

342.50K

+21.24%

Mr. Richard S. (Rich) Lindahl

Chief Financial Officer, Executive Vice President, Treasurer

196.50K

-2.48%

The Hon. Dr. Louis W. Sullivan, M.D.

Independent Director

118.86K

+40.74%

Dr. Zsolt Harsanyi, Ph.D.

Independent Chairman of the Board

103.49K

+49.80%

Dr. Simon C Lowry, M.D.

Chief Medical Officer, Head of Research and Development

91.98K

+211.99%

Ms. Coleen Glessner

Executive Vice President - Quality and Ethics and Compliance

90.86K

-25.20%

Mr. Ronald B. Richard

Independent Director

85.27K

+67.63%

Ms. Jessica Perl

Senior Vice President, General Counsel, Corporate Secretary

68.39K

+1061.66%

Mr. Marvin L. White

Independent Director

68.25K

+101.64%

Mr. Keith A. Katkin, CPA

Independent Director

66.14K

-10.60%

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Joseph C. (Joe) Papa

President, Chief Executive Officer, Director

342.50K

+21.24%

Mr. Richard S. (Rich) Lindahl

Chief Financial Officer, Executive Vice President, Treasurer

196.50K

-2.48%

The Hon. Dr. Louis W. Sullivan, M.D.

Independent Director

118.86K

+40.74%

Dr. Zsolt Harsanyi, Ph.D.

Independent Chairman of the Board

103.49K

+49.80%

Dr. Simon C Lowry, M.D.

Chief Medical Officer, Head of Research and Development

91.98K

+211.99%

Ms. Coleen Glessner

Executive Vice President - Quality and Ethics and Compliance

90.86K

-25.20%

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Commercial Product sales

67.50M

47.91%

MCM Product sales

58.40M

41.45%

Contracts and grants

15.00M

10.65%

Nach RegionUSD

Name

Umsatz

Anteil

Non-U.S Government

83.10M

58.98%

U.S.Government

57.80M

41.02%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Commercial Product sales

67.50M

47.91%

MCM Product sales

58.40M

41.45%

Contracts and grants

15.00M

10.65%

Aktionärsstatistik

Aktualisiert: Thu, Oct 16

Aktionäre

Aktionärstypen

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

7.29%

The Vanguard Group, Inc.

6.74%

American Century Investment Management, Inc.

4.36%

Dimensional Fund Advisors, L.P.

3.52%

State Street Investment Management (US)

3.31%

Andere

74.77%

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

7.29%

The Vanguard Group, Inc.

6.74%

American Century Investment Management, Inc.

4.36%

Dimensional Fund Advisors, L.P.

3.52%

State Street Investment Management (US)

3.31%

Andere

74.77%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

32.25%

Investment Advisor/Hedge Fund

25.29%

Hedge Fund

9.57%

Individual Investor

3.05%

Research Firm

2.97%

Pension Fund

1.05%

Bank and Trust

0.84%

Sovereign Wealth Fund

0.18%

Venture Capital

0.05%

Andere

24.74%

Institutionelle Beteiligung



Aktualisiert: Wed, Oct 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q3

404

37.65M

71.69%

-6.17M

2025Q2

444

39.60M

73.05%

-8.24M

2025Q1

472

38.22M

70.45%

-8.61M

2024Q4

475

36.31M

66.90%

-8.91M

2024Q3

485

33.46M

61.86%

-11.26M

2024Q2

503

32.16M

60.76%

-21.31M

2024Q1

512

37.52M

71.59%

-17.68M

2023Q4

531

43.49M

83.79%

-11.00M

2023Q3

581

43.88M

84.66%

-15.71M

2023Q2

596

48.59M

93.79%

-8.52M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

BlackRock Institutional Trust Company, N.A.

3.83M

7.18%

+2.25M

+141.83%

Jun 30, 2025

The Vanguard Group, Inc.

3.58M

6.72%

+370.21K

+11.52%

Jun 30, 2025

American Century Investment Management, Inc.

2.29M

4.3%

-5.46K

-0.24%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

1.85M

3.47%

+252.40K

+15.81%

Jun 30, 2025

State Street Investment Management (US)

1.74M

3.26%

+30.01K

+1.75%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.28M

2.4%

+666.71K

+108.89%

Jun 30, 2025

Oak Hill Advisors, L.P.

1.11M

2.09%

--

Jun 30, 2025

Charles Schwab Investment Management, Inc.

1.11M

2.07%

+521.91K

+89.48%

Jun 30, 2025

Palisade Capital Management, LLC

1.10M

2.06%

-41.83K

-3.66%

Jun 30, 2025

Marshall Wace LLP

1.02M

1.91%

-139.01K

-12.01%

Jun 30, 2025

Verbundene ETFs



Aktualisiert: Thu, Nov 6

Name

Anteil

Royce Quant Small-Cap Quality Value ETF

0.31%

SPDR S&P Biotech ETF

0.21%

Federated Hermes MDT Small Cap Core ETF

0.18%

Harbor Human Capital Factor US Small Cap ETF

0.13%

Pacer US Small Cap Cash Cows ETF

0.12%

Invesco RAFI US 1500 Small-Mid ETF

0.12%

Direxion Daily S&P Biotech Bull 3X Shares

0.11%

Avantis US Small Cap Value ETF

0.1%

iShares Micro-Cap ETF

0.09%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.09%

Royce Quant Small-Cap Quality Value ETF

Anteil0.31%

SPDR S&P Biotech ETF

Anteil0.21%

Federated Hermes MDT Small Cap Core ETF

Anteil0.18%

Harbor Human Capital Factor US Small Cap ETF

Anteil0.13%

Pacer US Small Cap Cash Cows ETF

Anteil0.12%

Invesco RAFI US 1500 Small-Mid ETF

Anteil0.12%

Direxion Daily S&P Biotech Bull 3X Shares

Anteil0.11%

Avantis US Small Cap Value ETF

Anteil0.1%

iShares Micro-Cap ETF

Anteil0.09%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

Anteil0.09%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten